Lincomycin hydrochloride

Lincomycin An antibiotic produced by Streptomyces lincolnensis var. lincolnensis. It has been used in the treatment of staphylococcal, streptococcal, and Bacteroides fragilis infections.

[1. Abbreviation for lymphocytic choriomeningitis; left costal margin.

Molecular Formula: C₁₈H₃₇ClN₂O₇S

InChI: InChI=1/C18H34N2O6S.ClH.H2O/c1-5-6-10-7-11(20(3)8-10)17(25)19-12(9(2)21)16-14(23)13(22)15(24)18(26-16)27-4;;/h9-16,18,21-24H,5-8H2,1-4H3,(H,19,25);1H;1H2/t9-,10-,11u,12-,13+,14-,15-,16-,18-;;/m1../s1/f/h19H;;

InChIKey: InChIKey=LFZGYTBWUHCAKF-LMVKATLTDO
SMILES: CCCC1CC(N(C1)C)C(=O)NC(C2C(C(C(C(O2)SC)O)O)O)C(C)O.O.Cl

Names:
    D02346
    LCM
    Lincocin (TN)
    Lincocin
    Lincomycin hydrochloride (JP15/USP)
    Lincomycin hydrochloride
    (4R)-N-[(1R,2R)-2-hydroxy-1-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylsulfanyl-oxan-2-yl]propyl]-1-methyl-4-propyl-pyrrolidine-2-carboxamide hydrate hydrochloride
    7179-49-9

Registries:
    PubChem CID 441186
    PubChem ID 7849405